Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxychloroquine in diabetes deserves particular attention for its documented hypoglycemic action.
Stoian A.P., Catrinoiu D., Rizzo M., Ceriello A. (2021). Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story. DIABETES/METABOLISM RESEARCH AND REVIEWS, 37(2) [10.1002/dmrr.3379].
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story
Rizzo M.;
2021-01-01
Abstract
Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxychloroquine in diabetes deserves particular attention for its documented hypoglycemic action.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
dmrr.3379 In press.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
240.51 kB
Formato
Adobe PDF
|
240.51 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
